Gestational diabetes and endothelial function: impact of gestational insulin resistance on reactive hyperhemia index
DOI:
https://doi.org/10.18203/2320-6012.ijrms20223312Keywords:
Gestational diabetes, Insulin resistance, Reactive hyperhemia index, Endothelial dysfunctionAbstract
Our aim was to characterize endothelial function in gestational diabetes by evaluating the reactive hyperemia index (RHI, LnRHI). A prospective, descriptive and comparative study was conducted on a population of pregnant women aged over 20 and under 36, located in the gestational age group 24-38th week of amenorrhea. They were divided into two groups. Group 1 (G1): group of pregnancies without diabetes, consists of pregnant women with no risk factor for gestational diabetes and with normal fasting blood glucose. Group 2 (G2): group of pregnancies with diabetes, includes pregnancies whose oral glucose tolerance tests (OGTT) came back positive. Anthropo-physiological parameters (age, weight, height, blood pressure (PA) and biochemical parameters (glycemia, insulinemia, HOMA-IR, cholesterol, triglycerides) were measured. RHI and LnRHI were determined at Endopat 2000. The two groups were matched for age, weight, heart rate (HR) and blood pressure (BP). Levels of glucose (G1:0.76±0.11; G2:1.11±0.11; p˂0.0001), insulin (G1:7.67±4.35; G2:22.9±3.75; p˂0.0001), HOMA-IR (G1:1.51±0.97; G2:6.29±1.23; p˂0.0001), total cholesterol (G1:1±0.81; G2:2.49±0.74; p=0.002), HDL cholesterol (G1:0.45±0.23; G2: 0.8±0.19; p=0.004, LDL cholesterol (G1:0.42±0.54; G2:1.39±0.6; p=0.004), triglycerides (G1:0.65±0.49; G2:1.48±0.27; p=0.0018), were significantly higher in the diabetic group. Both RHI and LnRHI were negatively correlated with HOMA-IR (respectively, r=-0.8931, p<0.0001; r=-0.8938; p<0.0001). HOMA-IR index was independently associated with levels of RHI and LnRHI (respectively r²=0.797; p<0.0001); (r²=0.804; p<0.0001)). Thus, gestational insulin resistance would be associated with a change in endothelial function such as a decrease in endothelium-dependent vasodilatation reflecting endothelial dysfunction, hence an increase in cardiovascular risk.
Metrics
References
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation. WHO Genève 2006; 46.
Mrizak I, Grissa O, Henault B, Fekih M, Bouslema A, Boumaiza I, et al. Placental infiltration of inflammatory markers in gestational diabetic women. General Physiology and Biophysics. 2014;33(2):169–76.
Boutouyrie P, Tropeano AI, Laurent S. Remodelage artériel dans le diabète. Sang Thrombose Vaisseaux. 2005;17(1):14-22.
EndoPATTM2000. Device User Manual Itamar Medical REF 75-OM1695214. Copyright © 2002-2019 by Itamar Medical Ltd. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.
Debbabi H, Bonnin P, Ducluzeau PH, Lefthériotis G, Levy BI. Noninvasive assessment of endothelial function in the skin microcirculation. Am J Hypertens. 2010;23(5):541-6.
Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Non-invasive assessment of micro vascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis. 2004;173:97-102.
Qi Fu, Benjamin DL: Autonomic circulatory control during pregnancy in humans. Semin Reprod Med. 2009;27(4):330-7.
Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, et al. Pregnancyrelated hyperlipidemia and endothelial function in healthy women. Circulation J. 2006;70(6):768-72.
Savvidou MD, Kametas NA, Donald AE, Nicolaides KH. Non invasive assessment of endothelial function in normal pregnancy. Ultrasound Obstet Gynecol. 2000;15:502-7.
Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovascular J Africa: Cardiovasc J Afr. 2016;27:89-9.
Manish Gutch, Sukriti Kumar, Syed Mohd Razi, Kumar Keshav Gupta, and Abhinav Gupta, Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015;19(1):160-4.
Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, Imagawa A, et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocrine J. 2013;60(3):283-90.
Baba T, Neugebauer S. The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity. Drugs. 1994;47(3):383-404.
Ribstein J, DuCailar G, Mimran A. Arterial hypertension, hyperinsulinism and insulin resistance Presse Med. 1992;21(28):1318-23.
DeFronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-94.
Carr DB. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29(9):2078-83.
Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy-Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24(4):515-25.
Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. The postpartum cardiovascular risk factor profile of women with 201 isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy. Nutr Metab Cardiovas Dis. 2011;21(9):706-12.
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
Chirayath H H, Wareing M, Taggart M J, Baker P N. Endothelial dysfunction in myometrial arteries of women with gestational diabetes. Diabetes Res Clin Pract. 2010;89(2):134-40.
Zawiejska A, Wender-Ożegowska E, Pietryga M, Brązert J. Maternal endothelial dysfunction and its association with abnormal fetal growth in diabetic pregnancy. Diabet Med. 2011;28(6):692-8.
Paradisi G, Biaggi A, Ferrazzani S, De, Carolis S, Caruso A: Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care. 2002;25 (3):560-4.
Khan NA. Inflammation and immunity: implications in obesity and type 2 diabetes. Oilseeds Fats Lipids. 2006;3(5):343-51.
Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes associated macrovasculopathy pathophysiology and pathogenesis. Diab Ob Meta. 2007;9(6):767-80.
Félétou M, Vanhoutte P M. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J physiol Heart Circ Physiol. 2006;291(3):985-1002.
Le Brocq M, Leslie S J, Milliken P, Megson I L. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 2008;10(9):1631-74.
Grover-Paez F, Zavalza-Gomez A. Endothelial dysfunction and cardiovascular risk factors. Diab Res Clin Pract. 2009;84(1):1-10.
Sattar N. Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease? Clin Sci. 2004;106(5):443-5.
Downloads
Published
How to Cite
Issue
Section
